Global Oligonucleotide API Market Research Report 2021
1 Oligonucleotide API Market Overview
- 1.1 Product Overview and Scope of Oligonucleotide API
- 1.2 Oligonucleotide API Segment by Type
- 1.2.1 Global Oligonucleotide API Market Size Growth Rate Analysis by Type 2021 VS 2027
- 1.2.2 Antisense Oligonucleotides API
- 1.2.3 Small Interfering RNA (siRNA) API
- 1.2.4 MiRNA API
- 1.2.5 CpG Oligonucleotides API
- 1.2.6 Others
- 1.3 Oligonucleotide API Segment by Application
- 1.3.1 Global Oligonucleotide API Consumption Comparison by Application: 2016 VS 2021 VS 2027
- 1.3.2 Contract Manufacturing Organizations (CMOs)
- 1.3.3 Pharmaceutical Companies
- 1.4 Global Market Growth Prospects
- 1.4.1 Global Oligonucleotide API Revenue Estimates and Forecasts (2016-2027)
- 1.4.2 Global Oligonucleotide API Production Capacity Estimates and Forecasts (2016-2027)
- 1.4.3 Global Oligonucleotide API Production Estimates and Forecasts (2016-2027)
- 1.5 Global Oligonucleotide API Market by Region
- 1.5.1 Global Oligonucleotide API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
- 1.5.2 North America Oligonucleotide API Estimates and Forecasts (2016-2027)
- 1.5.3 Europe Oligonucleotide API Estimates and Forecasts (2016-2027)
- 1.5.5 China Oligonucleotide API Estimates and Forecasts (2016-2027)
- 1.5.5 Japan Oligonucleotide API Estimates and Forecasts (2016-2027)
2 Market Competition by Manufacturers
- 2.1 Global Oligonucleotide API Production Capacity Market Share by Manufacturers (2016-2021)
- 2.2 Global Oligonucleotide API Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.4 Global Oligonucleotide API Average Price by Manufacturers (2016-2021)
- 2.5 Manufacturers Oligonucleotide API Production Sites, Area Served, Product Types
- 2.6 Oligonucleotide API Market Competitive Situation and Trends
- 2.6.1 Oligonucleotide API Market Concentration Rate
- 2.6.2 Global 5 and 10 Largest Oligonucleotide API Players Market Share by Revenue
- 2.6.3 Mergers & Acquisitions, Expansion
3 Production and Capacity by Region
- 3.1 Global Production Capacity of Oligonucleotide API Market Share by Region (2016-2021)
- 3.2 Global Oligonucleotide API Revenue Market Share by Region (2016-2021)
- 3.3 Global Oligonucleotide API Production, Revenue, Price and Gross Margin (2016-2021)
- 3.4 North America Oligonucleotide API Production
- 3.4.1 North America Oligonucleotide API Production Growth Rate (2016-2021)
- 3.4.2 North America Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 3.5 Europe Oligonucleotide API Production
- 3.5.1 Europe Oligonucleotide API Production Growth Rate (2016-2021)
- 3.5.2 Europe Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 3.6 China Oligonucleotide API Production
- 3.6.1 China Oligonucleotide API Production Growth Rate (2016-2021)
- 3.6.2 China Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 3.7 Japan Oligonucleotide API Production
- 3.7.1 Japan Oligonucleotide API Production Growth Rate (2016-2021)
- 3.7.2 Japan Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Oligonucleotide API Consumption by Region
- 4.1 Global Oligonucleotide API Consumption by Region
- 4.1.1 Global Oligonucleotide API Consumption by Region
- 4.1.2 Global Oligonucleotide API Consumption Market Share by Region
- 4.2 North America
- 4.2.1 North America Oligonucleotide API Consumption by Country
- 4.2.2 U.S.
- 4.2.3 Canada
- 4.3 Europe
- 4.3.1 Europe Oligonucleotide API Consumption by Country
- 4.3.2 Germany
- 4.3.3 France
- 4.3.4 U.K.
- 4.3.5 Italy
- 4.3.6 Russia
- 4.4 Asia Pacific
- 4.4.1 Asia Pacific Oligonucleotide API Consumption by Region
- 4.4.2 China
- 4.4.3 Japan
- 4.4.4 South Korea
- 4.4.5 Taiwan
- 4.4.6 Southeast Asia
- 4.4.7 India
- 4.4.8 Australia
- 4.5 Latin America
- 4.5.1 Latin America Oligonucleotide API Consumption by Country
- 4.5.2 Mexico
- 4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
- 5.1 Global Oligonucleotide API Production Market Share by Type (2016-2021)
- 5.2 Global Oligonucleotide API Revenue Market Share by Type (2016-2021)
- 5.3 Global Oligonucleotide API Price by Type (2016-2021)
6 Consumption Analysis by Application
- 6.1 Global Oligonucleotide API Consumption Market Share by Application (2016-2021)
- 6.2 Global Oligonucleotide API Consumption Growth Rate by Application (2016-2021)
7 Key Companies Profiled
- 7.1 Jazz Pharmaceuticals
- 7.1.1 Jazz Pharmaceuticals Oligonucleotide API Corporation Information
- 7.1.2 Jazz Pharmaceuticals Oligonucleotide API Product Portfolio
- 7.1.3 Jazz Pharmaceuticals Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.1.4 Jazz Pharmaceuticals Main Business and Markets Served
- 7.1.5 Jazz Pharmaceuticals Recent Developments/Updates
- 7.2 Sarepta Therapeutics
- 7.2.1 Sarepta Therapeutics Oligonucleotide API Corporation Information
- 7.2.2 Sarepta Therapeutics Oligonucleotide API Product Portfolio
- 7.2.3 Sarepta Therapeutics Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.2.4 Sarepta Therapeutics Main Business and Markets Served
- 7.2.5 Sarepta Therapeutics Recent Developments/Updates
- 7.3 Biogen
- 7.3.1 Biogen Oligonucleotide API Corporation Information
- 7.3.2 Biogen Oligonucleotide API Product Portfolio
- 7.3.3 Biogen Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.3.4 Biogen Main Business and Markets Served
- 7.3.5 Biogen Recent Developments/Updates
- 7.4 Dynavax Technologies
- 7.4.1 Dynavax Technologies Oligonucleotide API Corporation Information
- 7.4.2 Dynavax Technologies Oligonucleotide API Product Portfolio
- 7.4.3 Dynavax Technologies Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.4.4 Dynavax Technologies Main Business and Markets Served
- 7.4.5 Dynavax Technologies Recent Developments/Updates
- 7.5 Akcea Therapeutics
- 7.5.1 Akcea Therapeutics Oligonucleotide API Corporation Information
- 7.5.2 Akcea Therapeutics Oligonucleotide API Product Portfolio
- 7.5.3 Akcea Therapeutics Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.5.4 Akcea Therapeutics Main Business and Markets Served
- 7.5.5 Akcea Therapeutics Recent Developments/Updates
- 7.6 Alnylam Pharmaceuticals
- 7.6.1 Alnylam Pharmaceuticals Oligonucleotide API Corporation Information
- 7.6.2 Alnylam Pharmaceuticals Oligonucleotide API Product Portfolio
- 7.6.3 Alnylam Pharmaceuticals Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.6.4 Alnylam Pharmaceuticals Main Business and Markets Served
- 7.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
- 7.7 Nitto Denko (Avecia)
- 7.7.1 Nitto Denko (Avecia) Oligonucleotide API Corporation Information
- 7.7.2 Nitto Denko (Avecia) Oligonucleotide API Product Portfolio
- 7.7.3 Nitto Denko (Avecia) Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.7.4 Nitto Denko (Avecia) Main Business and Markets Served
- 7.7.5 Nitto Denko (Avecia) Recent Developments/Updates
- 7.8 Ajinomoto (GeneDesign)
- 7.8.1 Ajinomoto (GeneDesign) Oligonucleotide API Corporation Information
- 7.8.2 Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolio
- 7.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.8.4 Ajinomoto (GeneDesign) Main Business and Markets Served
- 7.7.5 Ajinomoto (GeneDesign) Recent Developments/Updates
- 7.9 RiboBio
- 7.9.1 RiboBio Oligonucleotide API Corporation Information
- 7.9.2 RiboBio Oligonucleotide API Product Portfolio
- 7.9.3 RiboBio Oligonucleotide API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
- 7.9.4 RiboBio Main Business and Markets Served
- 7.9.5 RiboBio Recent Developments/Updates
8 Oligonucleotide API Manufacturing Cost Analysis
- 8.1 Oligonucleotide API Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Key Raw Materials Price Trend
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Oligonucleotide API
- 8.4 Oligonucleotide API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.2 Oligonucleotide API Distributors List
- 9.3 Oligonucleotide API Customers
10 Market Dynamics
- 10.1 Oligonucleotide API Industry Trends
- 10.2 Oligonucleotide API Growth Drivers
- 10.3 Oligonucleotide API Market Challenges
- 10.4 Oligonucleotide API Market Restraints
11 Production and Supply Forecast
- 11.1 Global Forecasted Production of Oligonucleotide API by Region (2022-2027)
- 11.2 North America Oligonucleotide API Production, Revenue Forecast (2022-2027)
- 11.3 Europe Oligonucleotide API Production, Revenue Forecast (2022-2027)
- 11.4 China Oligonucleotide API Production, Revenue Forecast (2022-2027)
- 11.5 Japan Oligonucleotide API Production, Revenue Forecast (2022-2027)
12 Consumption and Demand Forecast
- 12.1 Global Forecasted Demand Analysis of Oligonucleotide API
- 12.2 North America Forecasted Consumption of Oligonucleotide API by Country
- 12.3 Europe Market Forecasted Consumption of Oligonucleotide API by Country
- 12.4 Asia Pacific Market Forecasted Consumption of Oligonucleotide API by Region
- 12.5 Latin America Forecasted Consumption of Oligonucleotide API by Country
13 Forecast by Type and by Application (2022-2027)
- 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
- 13.1.1 Global Forecasted Production of Oligonucleotide API by Type (2022-2027)
- 13.1.2 Global Forecasted Revenue of Oligonucleotide API by Type (2022-2027)
- 13.1.3 Global Forecasted Price of Oligonucleotide API by Type (2022-2027)
- 13.2 Global Forecasted Consumption of Oligonucleotide API by Application (2022-2027)
14 Research Finding and Conclusion
15 Methodology and Data Source
- 15.1 Methodology/Research Approach
- 15.1.1 Research Programs/Design
- 15.1.2 Market Size Estimation
- 15.1.3 Market Breakdown and Data Triangulation
- 15.2 Data Source
- 15.2.1 Secondary Sources
- 15.2.2 Primary Sources
- 15.3 Author List
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
Segment by Application
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
By Company
Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE